Factors affecting the spontaneous expulsion of the levonorgestrel-releasing intrauterine system
- PMID: 24825498
- DOI: 10.1016/j.ijgo.2014.02.017
Factors affecting the spontaneous expulsion of the levonorgestrel-releasing intrauterine system
Abstract
Objective: To estimate the incidence of, and identify risk factors for, spontaneous expulsion of the levonorgestrel-releasing intrauterine system (LNG-IUS).
Methods: Pre-insertion characteristics for 481 women who received the LNG-IUS at a single institution in the Republic of Korea between 2003 and 2011 were analyzed retrospectively. The median duration of follow-up was 13.4 months. Kaplan-Meier plots were constructed to estimate the time to occurrence of spontaneous expulsion in multiple subgroups.
Results: The overall crude incidence of spontaneous LNG-IUS expulsion was 9.6%. The cumulative incidence was 7.9%, 9.1%, and 9.6% at 1, 2, and 3 years, respectively. It was significantly higher in women with adenomyosis (9.1%, 10.6%, and 11.1%) or uterine leiomyoma (14.5%, 15.8%, and 15.8%) than in those with a normal uterus (3.6%, 4.1%, and 4.6%) (P=0.008). Women with heavy menstrual bleeding (11.0%, 12.7%, and 13.4%), dysmenorrhea (8.1%, 9.0%, and 10.0%), or pre-insertion receipt of gonadotropin-releasing hormone agonists (13.3%, 16.0%, and 17.3%) also had higher cumulative incidences than those without these conditions (P<0.05). Most (84.5%) women with a spontaneous expulsion chose to discontinue the device.
Conclusion: Clinicians need to be aware of the risk factors for spontaneous LNG-IUS expulsion because this can lead to a discontinuation of its use.
Keywords: Adenomyosis; Heavy menstrual bleeding; Intrauterine device expulsion; Levonorgestrel; Risk factors; Uterine leiomyoma.
Copyright © 2014 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.Hum Reprod. 2015 Jul;30(7):1580-8. doi: 10.1093/humrep/dev102. Epub 2015 May 19. Hum Reprod. 2015. PMID: 25990577
-
Comparison of two cohorts of women who expulsed either a copper-intrauterine device or a levonorgestrel-releasing intrauterine system.J Obstet Gynaecol Res. 2016 May;42(5):554-9. doi: 10.1111/jog.12939. Epub 2016 Jan 28. J Obstet Gynaecol Res. 2016. PMID: 26817571
-
Complication rates associated with levonorgestrel intrauterine system use in adolescents with developmental disabilities.J Pediatr Adolesc Gynecol. 2014 Feb;27(1):25-8. doi: 10.1016/j.jpag.2013.08.010. Epub 2013 Dec 4. J Pediatr Adolesc Gynecol. 2014. PMID: 24315712
-
Progestin-releasing intrauterine systems and leiomyoma.Contraception. 2007 Jun;75(6 Suppl):S130-3. doi: 10.1016/j.contraception.2007.01.012. Epub 2007 Mar 9. Contraception. 2007. PMID: 17531604 Review.
-
The role of different LNG-IUS therapies in the management of adenomyosis: a systematic review and meta-analysis.Reprod Biol Endocrinol. 2025 Feb 13;23(1):23. doi: 10.1186/s12958-025-01349-4. Reprod Biol Endocrinol. 2025. PMID: 39948612 Free PMC article.
Cited by
-
[Efficacy and adverse effects of levonorgestrel-releasing intrauterine system in treatment of adenomyosis].Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019 Apr 25;48(2):130-135. doi: 10.3785/j.issn.1008-9292.2019.04.02. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019. PMID: 31309749 Free PMC article. Chinese.
-
Clinical efficacy analysis of LNG-IUS tail anchoring to the superficial myometrium under hysteroscopic direct vision.BMC Surg. 2025 Aug 13;25(1):370. doi: 10.1186/s12893-025-02982-x. BMC Surg. 2025. PMID: 40804674 Free PMC article.
-
Association of the Timing of Postpartum Intrauterine Device Insertion and Breastfeeding With Risks of Intrauterine Device Expulsion.JAMA Netw Open. 2022 Feb 1;5(2):e2148474. doi: 10.1001/jamanetworkopen.2021.48474. JAMA Netw Open. 2022. PMID: 35226086 Free PMC article.
-
Uterine adenomyosis: an update for GPs.Br J Gen Pract. 2023 Oct 26;73(736):524-525. doi: 10.3399/bjgp23X735549. Print 2023 Nov. Br J Gen Pract. 2023. PMID: 37884370 Free PMC article. No abstract available.
-
The use of a menstrual cup as a risk factor for displacement of intrauterine devices: a case-control study.Contracept Reprod Med. 2025 May 6;10(1):33. doi: 10.1186/s40834-025-00366-3. Contracept Reprod Med. 2025. PMID: 40329407 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources